CVS Health
CVS
1,564 hedge funds and large institutions have $77.3B invested in CVS Health in 2016 Q3 according to their latest regulatory filings, with 91 funds opening new positions, 659 increasing their positions, 686 reducing their positions, and 82 closing their positions.
30% more call options, than puts
Call options by funds: $645M | Put options by funds: $497M
11% more first-time investments, than exits
New positions opened: 91 | Existing positions closed: 82
0.13% more ownership
Funds ownership: 82.38% → 82.51% (+0.13%)
1% less funds holding
Funds holding: 1,573 → 1,564 (-9)
4% less repeat investments, than reductions
Existing positions increased: 659 | Existing positions reduced: 686
8% less capital invested
Capital invested by funds: $84.3B → $77.3B (-$7B)
23% less funds holding in top 10
Funds holding in top 10: 176 → 136 (-40)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
+$859M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$444M |
| 3 |
IC
Institutional Capital
Chicago,
Illinois
|
+$230M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$195M |
| 5 |
IGIM
I.G. Investment Management
Winnipeg,
Manitoba, Canada
|
+$186M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$684M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$576M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$464M |
| 4 |
Renaissance Technologies
New York
|
-$274M |
| 5 |
Ninety One (UK)
London,
United Kingdom
|
-$201M |
CVS Hedge Fund Activity: Q3 2016 in Review
1,564 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q3 2016, worth a combined $77.3B — down 8.3% from $84.3B a quarter earlier.
Buyers outnumbered sellers: 91 funds opened new CVS positions and 82 closed out — a net gain of 9 holders — while 659 added to existing stakes and 686 trimmed.
The largest buyer was Barrow, Hanley, Mewhinney & Strauss, opening a new position worth an estimated $859M. The largest seller was Macquarie Group, cutting an estimated $684M.
- 1,564 institutional investors held CVS Health (CVS) as of Q3 2016, down from 1,573 in Q2 2016.
- Funds reported $77.3B of CVS Health stock for Q3 2016, down 8.3% quarter-over-quarter.
- 91 funds opened new CVS Health positions in Q3 2016 and 82 closed out, a net change of +9 holders.
- The largest CVS Health buyer in Q3 2016 was Barrow, Hanley, Mewhinney & Strauss, an estimated $859M added.
- The largest CVS Health seller in Q3 2016 was Macquarie Group, an estimated $684M sold.
Based on aggregated 13F filings for Q3 2016.